Integral Diagnostics Limited
ITGDF
$2.06
$0.687450.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.90% | 6.13% | 3.80% | 6.63% | 10.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.90% | 6.13% | 3.80% | 6.63% | 10.73% |
| Cost of Revenue | 7.87% | 6.68% | 3.90% | 7.28% | 12.03% |
| Gross Profit | 4.86% | 4.97% | 3.57% | 5.28% | 8.10% |
| SG&A Expenses | 6.47% | 5.84% | 3.60% | 6.91% | 11.57% |
| Depreciation & Amortization | 4.98% | 5.72% | 4.97% | 5.02% | 6.03% |
| Other Operating Expenses | -12.79% | -28.50% | -40.74% | -49.10% | -54.62% |
| Total Operating Expenses | 7.14% | 6.18% | 3.65% | 6.54% | 10.72% |
| Operating Income | 4.42% | 5.58% | 5.38% | 7.52% | 10.88% |
| Income Before Tax | 117.08% | -115.60% | -280.90% | -288.12% | -296.59% |
| Income Tax Expenses | -22.15% | -30.71% | -37.86% | -30.94% | -22.93% |
| Earnings from Continuing Operations | 109.91% | -69.91% | -335.28% | -350.28% | -368.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 109.91% | -69.91% | -335.28% | -350.28% | -368.67% |
| EBIT | 4.42% | 5.58% | 5.38% | 7.52% | 10.88% |
| EBITDA | 3.89% | 4.97% | 4.65% | 6.21% | 8.90% |
| EPS Basic | 109.93% | -70.67% | -334.81% | -348.05% | -364.10% |
| Normalized Basic EPS | 100.00% | 26.94% | -1.92% | -48.85% | -77.82% |
| EPS Diluted | 108.41% | -72.55% | -342.13% | -354.10% | -368.60% |
| Normalized Diluted EPS | 96.95% | 26.03% | -2.22% | -49.16% | -77.76% |
| Average Basic Shares Outstanding | 3.23% | 1.79% | 0.33% | 1.84% | 3.39% |
| Average Diluted Shares Outstanding | 3.76% | 1.99% | 0.23% | 1.49% | 2.79% |
| Dividend Per Share | -4.25% | -4.49% | -5.69% | -1.27% | 4.44% |
| Payout Ratio | 11.23% | 0.38% | -1.45% | -1.39% | -1.34% |